priors.science/reviews/alopecia-areata-treatment

Alopecia Areata Treatment

The current evidence on 15 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

15claims tracked
Weeklyre-scored against new papers
1 Established · 13 Likely · 1 Uncertain · 0 Doubtful  |  four-reviewer panel · PICO Framework
SignalClaimStandingEvidence certaintyCorpus
StableRitlecitinib effective in adolescent alopecia areataPediatric TreatmentEstablished86%10
StableBaricitinib SALT≤20 response in severe alopecia areataJAK Inhibitor EfficacyLikely84%20
StableAlopecia areata causes anxiety and depressionQuality Of LifeLikely84%11
StableBaricitinib effective in adolescent alopecia areataPediatric TreatmentLikely82%10
StableIntralesional steroids in patchy alopecia areataConventional And Biologic Systemic TreatmentsLikely80%8
StableBaricitinib retreatment recaptures responseTreatment Persistence And RelapseLikely78%11
StableRegrowth treatment improves quality of life in alopecia areataQuality Of LifeLikely78%9
StableDeuruxolitinib SALT≤20 response in alopecia areataJAK Inhibitor EfficacyLikely77%20
StableDupilumab limited efficacy in alopecia areataConventional And Biologic Systemic TreatmentsLikely77%8
StableRitlecitinib SALT≤20 response in alopecia areataJAK Inhibitor EfficacyLikely76%20
StableMethotrexate plus steroids 31% response in alopecia areataConventional And Biologic Systemic TreatmentsLikely75%9
StableJAK inhibitors herpes zoster risk in alopecia areataJAK Inhibitor SafetyLikely72%18
StableBaricitinib relapse after withdrawalTreatment Persistence And RelapseLikely71%20
StablePulse corticosteroids 75% response in alopecia areataConventional And Biologic Systemic TreatmentsLikely65%12
StableJAK inhibitors show no major adverse cardiovascular event risk in alopecia areataJAK Inhibitor SafetyUncertain58%15
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely65–84%Well supported, with some gaps or indirect evidence.
Uncertain40–64%Mixed or limited evidence. Genuinely open.
Doubtful15–39%Little support; the weight of evidence leans against it.
Refuted< 15%The evidence contradicts it — confidently false as stated.
Recent signal
strengthenedNew evidence raised the certainty since the last review.
weakenedNew evidence lowered the certainty since the last review.
newA claim added to the review recently.
StableNo recent change to the standing.
Standing, evidence certainty and corpus are always shown. The study behind each move, why it moved, and the sceptic’s challenge are delivered to subscribers.
Update your priors.Track this topic